Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glycolysis-Based Genes Associated with the Clinical Outcome of Pancreatic Ductal Adenocarcinoma Identified by The Cancer Genome Atlas Data Analysis

22 Jan 2020

Abstract excerpt

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadly tumors in digestive tract tumors. Although there has been advancement in PDAC treatment, its prognosis still remains unsatisfactory, mainly because of dismal diagnosis. This article aims to develop new prognostic factors related to energy metabolism in PDAC and to use these genes for novel risk stratification. Hundred fifty messenger RNA (mRNA)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Pancreatic and Hepatic Oncology Research
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31968179
DOI: 10.1089/dna.2019.5089

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glycolysis-Based Genes Associated with the Clinical Outcome of Pancreatic Ductal Adenocarcinoma Identified by The Cancer Genome Atlas Data AnalysisPMID 31968179Read ↗

Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

Identification of a glycolysis-related gene signature for predicting pancreatic cancer survivalSemantic proximity Read ↗

The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis predictionSemantic proximity Read ↗

Development and Validation of a Novel Glycolysis-Related Risk Signature for Predicting Survival in Pancreatic AdenocarcinomaSemantic proximity Read ↗

Deciphering the genomic and lncRNA landscapes of aerobic glycolysis identifies potential therapeutic targets in pancreatic cancer.Semantic proximity Read ↗

Glycometabolic rearrangements–aerobic glycolysis in pancreatic ductal adenocarcinoma (PDAC): roles, regulatory networks, and therapeutic potentialSemantic proximity Read ↗

Altered Gene Expression along the Glycolysis–Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic CancerSemantic proximity Read ↗

Hypoxia- and Lactate Metabolism-Associated Prognostic and Therapeutic Signature in Pancreatic CancerSemantic proximity Read ↗

A glycolysis-related gene signature predicts prognosis of patients with esophageal adenocarcinomaSemantic proximity Read ↗

A metabolism-relevant signature as a predictor for prognosis and therapeutic response in pancreatic cancer.Semantic proximity Read ↗

Glycolysis Changes the Microenvironment and Therapeutic Response Under the Driver of Gene Mutation in Esophageal AdenocarcinomaSemantic proximity Read ↗

Molecular signatures of tumor progression in pancreatic adenocarcinoma identified by energy metabolism characteristicsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.